volume 52 issue 39 pages 12651-12666

Novel mammalian cell cycle inhibitors, spirotryprostatins A and B, produced by Aspergillus fumigatus, which inhibit mammalian cell cycle at G2/M phase

Cheng-Bin CUI
Hideaki Kakeya
H. OSADA
Publication typeJournal Article
Publication date1996-09-01
scimago Q3
wos Q2
SJR0.426
CiteScore4.1
Impact factor2.2
ISSN00404020, 14645416
Organic Chemistry
Drug Discovery
Biochemistry
Found 
Found 

Top-30

Journals

5
10
15
20
25
30
35
40
45
Tetrahedron Letters
42 publications, 8.43%
RSC Advances
30 publications, 6.02%
Tetrahedron
28 publications, 5.62%
Organic and Biomolecular Chemistry
19 publications, 3.82%
Journal of Organic Chemistry
17 publications, 3.41%
Organic Letters
15 publications, 3.01%
Molecules
13 publications, 2.61%
Journal of Heterocyclic Chemistry
12 publications, 2.41%
Journal of Molecular Structure
10 publications, 2.01%
Chemical Communications
10 publications, 2.01%
European Journal of Medicinal Chemistry
9 publications, 1.81%
European Journal of Organic Chemistry
9 publications, 1.81%
Chemistry - A European Journal
9 publications, 1.81%
Molecular Diversity
8 publications, 1.61%
ChemistrySelect
8 publications, 1.61%
Angewandte Chemie
7 publications, 1.41%
Natural Product Reports
7 publications, 1.41%
New Journal of Chemistry
7 publications, 1.41%
Asian Journal of Organic Chemistry
6 publications, 1.2%
Synlett
6 publications, 1.2%
Journal of Chemical Research
5 publications, 1%
Angewandte Chemie - International Edition
5 publications, 1%
Organic Chemistry Frontiers
5 publications, 1%
Chemistry of Heterocyclic Compounds
4 publications, 0.8%
Bioorganic and Medicinal Chemistry
4 publications, 0.8%
Marine Drugs
4 publications, 0.8%
Bioorganic and Medicinal Chemistry Letters
4 publications, 0.8%
Chirality
4 publications, 0.8%
Advanced Synthesis and Catalysis
4 publications, 0.8%
5
10
15
20
25
30
35
40
45

Publishers

20
40
60
80
100
120
140
Elsevier
131 publications, 26.31%
Wiley
92 publications, 18.47%
Royal Society of Chemistry (RSC)
88 publications, 17.67%
American Chemical Society (ACS)
49 publications, 9.84%
Springer Nature
31 publications, 6.22%
MDPI
26 publications, 5.22%
Taylor & Francis
14 publications, 2.81%
Georg Thieme Verlag KG
10 publications, 2.01%
SAGE
7 publications, 1.41%
Bentham Science Publishers Ltd.
5 publications, 1%
Pleiades Publishing
4 publications, 0.8%
Beilstein-Institut
3 publications, 0.6%
International Union of Crystallography (IUCr)
3 publications, 0.6%
The Society of Synthetic Organic Chemistry, Japan
3 publications, 0.6%
Oxford University Press
2 publications, 0.4%
World Scientific
2 publications, 0.4%
Shanghai Institute of Organic Chemistry
2 publications, 0.4%
Frontiers Media S.A.
2 publications, 0.4%
King Saud University
2 publications, 0.4%
The Japan Institute of Heterocyclic Chemistry
2 publications, 0.4%
Walter de Gruyter
1 publication, 0.2%
Pharmaceutical Society of Japan
1 publication, 0.2%
Pharmaceutical Society of Korea
1 publication, 0.2%
IOP Publishing
1 publication, 0.2%
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 0.2%
Asian Journal of Chemistry
1 publication, 0.2%
Publishing House for Science and Technology, Vietnam Academy of Science and Technology (Publications)
1 publication, 0.2%
Pensoft Publishers
1 publication, 0.2%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 0.2%
20
40
60
80
100
120
140
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
498
Share
Cite this
GOST |
Cite this
GOST Copy
CUI C., Kakeya H., OSADA H. Novel mammalian cell cycle inhibitors, spirotryprostatins A and B, produced by Aspergillus fumigatus, which inhibit mammalian cell cycle at G2/M phase // Tetrahedron. 1996. Vol. 52. No. 39. pp. 12651-12666.
GOST all authors (up to 50) Copy
CUI C., Kakeya H., OSADA H. Novel mammalian cell cycle inhibitors, spirotryprostatins A and B, produced by Aspergillus fumigatus, which inhibit mammalian cell cycle at G2/M phase // Tetrahedron. 1996. Vol. 52. No. 39. pp. 12651-12666.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/0040-4020(96)00737-5
UR - https://doi.org/10.1016/0040-4020(96)00737-5
TI - Novel mammalian cell cycle inhibitors, spirotryprostatins A and B, produced by Aspergillus fumigatus, which inhibit mammalian cell cycle at G2/M phase
T2 - Tetrahedron
AU - CUI, Cheng-Bin
AU - Kakeya, Hideaki
AU - OSADA, H.
PY - 1996
DA - 1996/09/01
PB - Elsevier
SP - 12651-12666
IS - 39
VL - 52
SN - 0040-4020
SN - 1464-5416
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{1996_CUI,
author = {Cheng-Bin CUI and Hideaki Kakeya and H. OSADA},
title = {Novel mammalian cell cycle inhibitors, spirotryprostatins A and B, produced by Aspergillus fumigatus, which inhibit mammalian cell cycle at G2/M phase},
journal = {Tetrahedron},
year = {1996},
volume = {52},
publisher = {Elsevier},
month = {sep},
url = {https://doi.org/10.1016/0040-4020(96)00737-5},
number = {39},
pages = {12651--12666},
doi = {10.1016/0040-4020(96)00737-5}
}
MLA
Cite this
MLA Copy
CUI, Cheng-Bin, et al. “Novel mammalian cell cycle inhibitors, spirotryprostatins A and B, produced by Aspergillus fumigatus, which inhibit mammalian cell cycle at G2/M phase.” Tetrahedron, vol. 52, no. 39, Sep. 1996, pp. 12651-12666. https://doi.org/10.1016/0040-4020(96)00737-5.